Enfusion/ENFN

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Enfusion

Enfusion, Inc. provides software-as-a-service (SaaS) platform for investment managers. The Company, through its software, analytics, and middle/back-office managed services, creates enterprise-wide cultures of real-time, data-driven intelligence and collaboration. The Company's cloud-native, end-to-end solution gives its clients the ability to access and analyze investment information in real time, perform complex calculations and interact with markets electronically adding up to better, more informed investment decisions and actions. Its solution is highly configurable to different work streams, client segments and asset classes. The Company's solution includes portfolio management system, order and execution management system, accounting/general ledger system, Enfusion Analytics System and technology-powered, managed services. Its solution is utilized by a variety of users, including portfolio managers, traders, compliance officers, operational support staff and executive management.

Ticker

ENFN

Sector

Technology

Trading on

NYSE

Industry

Software & Programming

Headquarters

Chicago, United States

Employees

1,102

Website

-

Enfusion Metrics

BasicAdvanced
$1.2B
Market cap
318.55
P/E ratio
$0.03
EPS
-
Beta
-
Dividend rate
$1.2B
$11.56
$7.52
8.7
4.075
253.536
3.27%
4.29%
5.37%
318.551
6.638
20.76
20.765
73.624
15.55%
0.99%
29.93%
25.79%

What the Analysts think about Enfusion

Analyst Ratings

Majority rating from 8 analysts.
Hold

Enfusion Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-1.04% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$48M
3.45%
Net income
-$500K
-183.33%
Profit margin
-1.04%
-180.62%

Enfusion Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 65.52%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.04
$0.04
$0.04
$0.06
-
Expected
$0.04
$0.05
$0.05
$0.04
$0.06
Surprise
-4.11%
-12.50%
-23.81%
65.52%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Enfusion stock?

Enfusion (ENFN) has a market cap of $1.2B as of June 22, 2024.

What is the P/E ratio for Enfusion stock?

The price to earnings (P/E) ratio for Enfusion (ENFN) stock is 318.55 as of June 22, 2024.

Does Enfusion stock pay dividends?

No, Enfusion (ENFN) stock does not pay dividends to its shareholders as of June 22, 2024.

When is the next Enfusion dividend payment date?

Enfusion (ENFN) stock does not pay dividends to its shareholders.

What is the beta indicator for Enfusion?

Enfusion (ENFN) does not currently have a Beta indicator.

What is the Enfusion stock price target?

The target price for Enfusion (ENFN) stock is $9.96, which is NaN% below the current price of $. This is an average based on projections from 6 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Enfusion stock

Buy or sell Enfusion stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing